Novo Nordisk boosts value amid weight-loss drugs frenzy

Wegovy weight loss drug. The market value of Novo Nordisk, the Danish company that makes Wegovy, continued to rise this week.

Little more than a month since becoming Europe’s most valuable listed company, Novo Nordisk has stretched its lead to over $100bn (€95bn) as the buzz around weight-loss drugs gets ever louder.

The Danish pharmaceutical maker overtook Louis Vuitton at the beginning of last month, and since then has accelerated clear as its rising share price has coincided with a slump in luxury stocks.